BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2013
View Archived Issues
Lexicon Pharmaceuticals reports data on novel SGLT inhibitors for diabetes
Read More
The reclassification of endometrial carcinoma subgroup categorization on a genomic basis
Read More
Results of phase I expansion study of CC-223 reported
Read More
Preclinical data support therapeutic efficacy of UR-1102 for hyperuricemia and gout
Read More
Results from first-in-human study of VXM-01 reported
Read More
NOX-G16, a new candidate for type 1 diabetes
Read More
Roche presents novel agents for HCV infection
Read More
Forma Therapeutics and Cancer Research Technology to discover cancer drugs
Read More
Omthera Pharmaceuticals submits NDA for Epanova to the FDA
Read More
Boehringer Ingelheim discloses novel ACC-beta inhibitors
Read More
Lorus Therapeutics reports phase I data for LOR-253
Read More
Novel CRTH2 receptor antagonists prepared by Actelion Pharmaceuticals
Read More
Bellicum Pharmaceuticals begins trial of novel controlled dendritic cell immunotherapy
Read More
Chelsea Therapeutics resubmits Northera NDA
Read More
Olema Pharmaceuticals divulges new estrogen receptor modulators
Read More
Immunocore and GSK partner to discover ImmTACs against novel targets
Read More
Imetelstat shows promise in phase II trial for the treatment of essential thrombocythemia
Read More
Acorda Therapeutics acquires two neuropathic pain assets
Read More
Sensorion and Griffin receive Eurostars grant to develop new therapies for vestibular disorders
Read More
Sorrento and Ben-Gurion University sign agreement to develop anti-HCV antibodies
Read More
Calimmune commences phase I/II trial of gene medicine for HIV
Read More
Nuvilex to advance cell-encapsulated anticancer drug to phase III trials
Read More
Advancell grants Helsinn worldwide license to drug for chemotherapy-induced dermatological injuries
Read More
Kinex Pharmaceuticals to lead Orascovery program development in China
Read More